NIH Acting Director Matthew Memoli Extends Appointments of Neuroscience Lab Heads

In a significant move, Dr. Matthew J. Memoli, the acting director of the U.S. National Institutes of Health (NIH), has extended the appointments of three prominent neuroscience lab heads at the National Institute of Mental Health (NIMH). The decision, announced on March 7, 2025, affects Dr. Mark Histed, Dr. Soohyun Lee, and Dr. Tobias Merson,…

Read More

CDC Plans Study on Vaccines and Autism Despite Decades of Evidence to the Contrary

CDC Embarks on Study of Vaccines and Autism Despite Clear Scientific Consensus The Centers for Disease Control and Prevention (CDC) has announced plans to conduct a comprehensive study into the alleged link between vaccines and autism, a move that has sparked both concern and debate. This decision comes despite decades of scientific research consistently showing…

Read More

Al Jaddaf Rotana Suite Hotel Achieves Certified Autism Center Status

In a significant milestone for inclusivity in hospitality, Al Jaddaf Rotana Suite Hotel has been awarded the prestigious Certified Autism Center (CAC) designation by the International Board of Credentialing and Continuing Education Standards (IBCCES). This achievement underscores the hotel’s commitment to creating a welcoming environment for autistic and sensory-sensitive individuals, aligning with Dubai’s broader initiative…

Read More

How Coding Helped a Neurodiverse Individual Thrive

The article “Finding Productivity Through Coding: A Neurodiverse Journey” by Doug Hawes shares his personal journey of self-discovery and overcoming challenges as a neurodiverse individual diagnosed with autism at the age of 20. Here’s a summary of his story and insights: Background and Early Life Introduction to Coding Productivity and Neurodiversity Strategies for Productivity Future…

Read More

Canada’s Ambitious Plan to Decode Childhood Neurodevelopment

Holland Bloorview Kids Rehabilitation Hospital is leading a groundbreaking national precision health initiative for children and youth, focusing on neurodevelopmental conditions, mental health, and brain injuries12. This initiative is part of the larger Canadian Precision Health Initiative (CPHI), which aims to build Canada’s largest-ever collection of human genomic data12. The project at Holland Bloorview will…

Read More

FDA Approves Phase 2 Trial for Cannabis-Based Autism Treatment

The U.S. Food and Drug Administration (FDA) has granted clearance for Defloria Pharmaceuticals to proceed with a Phase 2 clinical trial of its cannabis-based treatment for autism spectrum disorder (ASD). This development marks a significant step forward in exploring the potential of cannabis-derived compounds for managing autism symptoms. Defloria’s investigational new drug, DFLO-001, is specifically…

Read More

Trump’s NIH Nominee Sparks Controversy Over Vaccine-Autism Research Comments

In a contentious Senate confirmation hearing on March 5, 2025, Dr. Jay Bhattacharya, President Donald Trump’s nominee to lead the National Institutes of Health (NIH), ignited a firestorm of debate with his comments on vaccine safety and autism research. Bhattacharya, a Stanford University professor of medicine, expressed openness to funding new studies exploring potential links…

Read More